| No. |
제목 |
작성자 |
작성일 |
조회 |
| 9 |
(주)아이비스바이오 임시 주주 총회
관리자
23.10.13
조회 : 1,285
|
관리자 |
23.10.13 |
1,285 |
| 8 |
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.
관리자
23.10.13
조회 : 1,218
|
관리자 |
23.10.13 |
1,218 |
| 7 |
Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury.
관리자
23.10.13
조회 : 1,180
|
관리자 |
23.10.13 |
1,180 |
| 6 |
3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation
관리자
23.10.13
조회 : 1,172
|
관리자 |
23.10.13 |
1,172 |
| 5 |
Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.
관리자
23.10.13
조회 : 1,169
|
관리자 |
23.10.13 |
1,169 |
| 4 |
Researches on immunomodulatory imides drug development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Int J Mol Sci. (July 31, 2021).
관리자
23.10.13
조회 : 1,123
|
관리자 |
23.10.13 |
1,123 |
| 3 |
The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, ACS P
관리자
23.10.13
조회 : 1,176
|
관리자 |
23.10.13 |
1,176 |
| 2 |
Research on the immunomodulatory imide drugs development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Frontiers in Neuroscience (March 2
관리자
23.10.13
조회 : 1,178
|
관리자 |
23.10.13 |
1,178 |
| 1 |
The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, eLife
관리자
23.10.13
조회 : 1,125
|
관리자 |
23.10.13 |
1,125 |
